-
Donald Trump and Kamala Harris want to take on the pharmaceutical companies. The vice president is seen as more aggressive on the issue, but the former president's allies say it would be a top priority.
-
In a court filing, the administration says it has no timeline on whether it will allow states to import drugs from Canada, an effort approved under President Donald Trump as a strategy to control costs.
-
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.
-
The convenience of getting prescriptions filled at a kiosk could soon be a reality, under a bill moving through the state House.But not everyone agrees…
-
As the courts consider various lawsuits against drugmakers, researchers estimate what opioid addiction is costing our economy and what it would take to end the crisis.
-
The Miami-Dade County School Board has filed a federal lawsuit against more than a dozen corporations that manufacture or distribute opioids, claiming...
-
The rule, which had support from the Trump administration and consumer rights advocates, is a blow to the White House searching for ways to pressure pharmaceutical companies to lower prices.
-
Mind Fixers, by historian Anne Harrington, takes a hard look at the ways the marketing of a new pill to treat a mental disorder can change the way the condition is defined and treated.
-
Senators got their first opportunity Tuesday to prod drugmakers about the wallet-emptying prices they charge for prescription drugs. Almost in unison, the…
-
Installment plans and refunds for treatments that don't work are two options getting more attention as ultra-expensive therapies become more common. The financial strains will only grow.